Raising Health

Pushmeet Kohli and Vijay Pande discuss the transformative power of AI in science, focusing on AlphaFold's impact on protein structure prediction, revolutionizing biology, drug design, and research economics. They explore the accessibility of AI tools, decision-making in open-sourcing models, and the exciting future of AI advancements in scientific discovery.

Chronis Manolis, SVP and Chief Pharmacy Officer of UPMC Health Plan, discusses the perspectives of payors and providers on anti-obesity medications, focusing on pricing and prior authorization challenges. The podcast delves into the scientific and supply aspects of GLP-1s, exploring the evolution of these drugs in healthcare, the importance of holistic support in drug prescriptions, strategies for optimizing pharmacy spend, and insights into incorporating these drugs into healthcare benefits packages.

Brooke Boyarsky Pratt, CEO of knownwell, discusses obesity medicine, patient-centric care, and the future of metabolic health. Topics include GLP-1s for insulin regulation, improving patient access to medications, and the founder's transition from business to healthcare passion.

Carolyn Jasik, Chief Medical Officer of Omada Health, discusses the science of GLP-1 medications, including satiety effects, perspectives of obesity-focused physicians, and lifestyle implications for patients. They explore the transformative potential, comprehensive care strategies, and impact on behavior change. Practical tips for healthy eating on the go are also shared.

Vineeta Agarwala, MD, PhD, discusses AI for drug discovery and her work as a physician. Topics include AI in drug discovery, biotech acquisitions in Seattle, tech-driven innovation in biotech investments, compassionate care in biotech, impact of AI in healthcare, and future of drug discovery in a high-tech world.

Kim Branson, SVP and Global Head of AI and Machine Learning for GSK, discusses how AI has revolutionized drug discovery and development, highlighting its applications in the lab. They also delve into the criteria for an ideal biopharma partner and the allure of innovative solutions in the biotech AI space.

Pioneering immunologist, Carl June, discusses his work on CAR T cell therapy, including its origins in HIV treatment, effectiveness in treating B cell malignancies, challenges with cytokine storms, and future prospects for cancer treatment advancements.

Tom Hale, CEO of ŌURA, discusses the potential of wearables to change behavior and improve health. They explore how AI can maximize wearable usefulness, impact of wearables on sleep quality, consumerization of healthcare through wearables, health monitoring studies, personal sleep tips, and the correlation between sleep and NBA player performance.

Philip Tagari, Chief Scientific Officer of insitro, and Vijay Pande discuss the transformative power of drug discovery, evolution of the process with AI, and the future of the industry. Topics include AI-enabled drug engineering, personalized healthcare, and blending tech and life sciences for optimal results.

Two healthcare innovators, Ed and Todd Park, discuss the urgent need for AI in healthcare and their journey of building Devoted Health from scratch. They emphasize aligning payment with quality care, integrating technology, and the transformative power of AI in improving patient outcomes by 2030.